CORRELATION BETWEEN ASPROSIN AND SPEXIN LEVELS IN IRAQI CHILDREN WITH GROWTH HORMONE DEFICIENCY
DOI:
https://doi.org/10.21272/eumj.2025;13(2):536-543Keywords:
Asprosin; Spexin; GHD; IGF-1; Iraqi childrenAbstract
Introduction: Growth hormone deficiency (GHD) is an endocrine disorder that causes a reduction in the synthesis of growth hormone (GH) in children, leading to short stature and delayed puberty. Insulin-like growth factor-I (IGF-1) plays a critical role in the growth-promoting effect of GH. IGF-1 levels provide information about the body’s natural release of GH. Asprosin (ASP) is a modernly recognized adipokine produced from adipose tissue linked to metabolic disorders like obesity and diabetes. Spexin (SPX) is a newly discovered adipokine implicated in various homeostatic functions, including metabolism, endocrine processes, and GH production. This study suggests a special relationship between GH, ASP, and SPX in GHD children.
Methods: investigates the potential correlation between ASP and SPX in 90 children, 40 with GHD, and 50 healthy controls. Levels of growth hormone, insulin-like growth factor-1, and vitamin D3 were measured in both groups. SPX and ASP levels were measured by using enzyme-linked immunoassay.
Results: biochemical parameters between the patient and control group showed significant differences in Hb, Vit.D3, ASP, SPX, and GH p< 0.050, In the correlation study, GH showed a significant negative correlation with ASP, SPX, and Hb (p = 0.015, p = 0.000 and p = 0.024 respectively), but show a positive correlation with D3.
Conclusion: ASP could be one of the underlying factors contributing to GHD through influencing metabolic processes linked to GH regulation. Also, differences in SPX levels may play a role in the etiology of GHD, as SPX is proven to be expressed in all endocrine glands.
Downloads
References
Utiger RD. Growth hormone. Encyclopedia Britannica, 2024;23 Oct. https://www.britannica.com/science/growth-hormone.
Dos Santos WO, Gusmao DO, Wasinski F, List EO, Kopchick JJ, Donato J. Effects of growth hormone receptor ablation in corticotropin-releasing hormone cells. Int J Mol Sci. 2021;22(18):9908-23. https://doi.org/10.3390/ijms22189908
Tavares MR, Frazao R, Donato J. Understanding the role of growth hormone in situations of metabolic stress. J Endocrinol. 2022;256(1):e220159. https://doi.org/10.1530/JOE-22-0159
Bozzola M, Meazza C. Growth hormone deficiency: diagnosis and therapy in children. In: Restricted Growth - Clinical, Genetic and Molecular Aspects (Ed.). InTech. 2016. https://doi.org/10.5772/64803
Brod M, Alolga SL, Beck JF, Wilkinson L, Højbjerre L, Rasmussen MH. Understanding burden of illness for child growth hormone deficiency. Qual Life Res. 2017;26(7):1673-1686. https://doi.org/10.1007/s11136-017-1529-1
Lillis J, Hayes SC, Bunting K, Masuda A. Teaching acceptance and mindfulness to improve the lives of the obese: A preliminary test of a theoretical model. Ann Behav Med. 2009;37:58-69. https://doi.org/10.1007/s12160-009-9083-x
Ibba A, Guzzetti C, Sanfilippo L, Loche S. Isolated growth hormone deficiency. Endocrines. 2024;5(3):341-353. https://doi.org/10.3390/endocrines5030025
Blum WF, Alherbish A, Alsagheir A, El Awwa A, Kaplan W, Koledova E, Savage MO. The growth hormone–insulin-like growth factor-I axis in the diagnosis and treatment of growth disorders. Endocr Connect. 2018;6:R212-R222. https://doi.org/10.1530/EC-18-0099
Obara-Moszynska M, Kctdzia A, Korman E, Niedziela M. Usefulness of growth hormone (GH) stimulation tests and IGF-1 concentration measurement in GH deficiency diagnosis. J Pediatr Endocrinol Metab. 2008;21(6):569-580. PMID: 18717243
Juul A, Skakkebaek NE. Prediction of the outcome of growth hormone provocative testing in short children by measurement of serum levels of insulin-like growth factor I and insulin-like growth factor binding protein 3. J Pediatr. 1997;130(2):197-204. https://doi.org/10.1016/s0022-3476(97)70343-3
González-Rodríguez M, Ruiz-Fernández C, Cordero-Barreal A, Eldjoudi DA, Pino J, Farrag Y, Gualillo O. Adipokines as targets in musculoskeletal immune and inflammatory diseases. Drug Discov Today. 2022;27(11):103352. https://doi.org/10.1016/j.drudis.2022.103352
Romere C, Duerrschmid C, Bournat J, Constable P, Jain M, Xia F. Asprosin, a fasting-induced glucogenic protein hormone. Cell. 2016;165:566-579. https://doi.org/10.1016/j.cell.2016.02.063
Li E, Shan H, Chen L, Long A, Zhang Y, Liu Y. OLFR734 mediates glucose metabolism as a receptor of asprosin. Cell Metab. 2019;30:319-328.e8. https://doi.org/10.1016/j.cmet.2019.05.022
Liu Y, Long A, Chen L, Jia L, Wang Y. The asprosin–OLFR734 module regulates appetitive behaviors. Cell Discov. 2020;6(1):19. https://doi.org/10.1038/s41421-020-0152-4
Alan M, Gurlek B, Yilmaz A, Aksit M, Aslanipour B, Gulhan I, Taner CE. Asprosin: a novel peptide hormone related to insulin resistance in women with polycystic ovary syndrome. Gynecol Endocrinol. 2019;35(3):220-223. https://doi.org/10.1080/09513590.2018.1512967
Zhang L, Chen C, Zhou N, Fu Y, Cheng X. Circulating asprosin concentrations are increased in type 2 diabetes mellitus and independently associated with fasting glucose and triglyceride. Clin Chim Acta. 2019;489:183-188. https://doi.org/10.1016/j.cca.2017.10.034
Ateah N, Abed AY, Abed BA. Evaluation of asprosin hormone in hypothyroidism patients. Ibn Al-Haitham J Pure Appl Sci. 2023;36(2):224-231. https://doi.org/10.30526/36.2.3008
Ehssan S, Abed BA, Salman IN, Ghannawi LA. Review of asprosin as a new biomarker for diagnosis of different diseases. Univ Thi-Qar J Sci. 2023;10(2):160-164. https://doi.org/10.32792/utq/utjsci/v10i2.1125
Ke X, Duan L, Gong F, Zhang Y, Deng K, Yao Y, Wang L, Pan H, Zhu H. Serum levels of asprosin, a novel adipokine, are significantly lowered in patients with acromegaly. Int J Endocrinol. 2020;2020:8855996. https://doi.org/10.1155/2020/8855996
Mohammed S, Alabedi R. The role of asprosin and ceramides in the development of growth hormone deficiency in children. Med J Babylon. 2022;19. https://doi.org/10.4103/MJBL.MJBL_231_22
Li X, Liao M, Shen R, Zhang L, Hu H, Wu J. Plasma asprosin levels are associated with glucose metabolism, lipid, and sex hormone profiles in females with metabolic-related diseases. Mediators Inflamm. 2018;1-12. https://doi.org/10.1155/2018/7375294
Lee T, Yun S, Jeong JH, Jung TW. Asprosin impairs insulin secretion in response to glucose and viability through TLR4/JNK-mediated inflammation. Mol Cell Endocrinol. 2019;486:96-104. https://doi.org/10.1016/j.mce.2019.03.001
Jung TW, Kim HC, Kim HU, et al. Asprosin attenuates insulin signaling pathway through PKCδ-activated ER stress and inflammation in skeletal muscle. J Cell Physiol. 2019;234:20888-20899. https://doi.org/10.1002/jcp.28694
Darakcı Ö, Bozkurt A. Structure and functions of spexin as a new neuroendocrine signal. J Exp Clin Med. 2022;39(3):893-900. https://doi.org/10.52142/omujecm.39.3.56
Ma A, Bai J, He M, Wong A. Spexin as a neuroendocrine signal with emerging functions. Gen Comp Endocrinol. 2018;265. https://doi.org/10.1016/j.ygcen.2018.01.015
Hodges SK, Teague AM, Dasari PS, Short KR. Effect of obesity and type 2 diabetes, and glucose ingestion on circulating spexin concentration in adolescents. Pediatr Diabetes. 2018;19(2):212-216. https://doi.org/10.1111/pedi.12549
Ma A, He M, Bai J, Wong MK, Ko WK, Wong AO. Dual role of insulin in spexin regulation: functional link between food intake and spexin expression in a fish model. Endocrinology. 2017;158(3):560-577. https://doi.org/10.1210/en.2016-1534
Lv SY, Cui B, Yang Y, Du H, Zhang X, Zhou Y, et al. SPX/NPQ induces FBJ osteosarcoma oncogene (Fos) and produces antinociceptive effect against inflammatory pain in the mouse model. Am J Pathol. 2019;189(4):886-899. https://doi.org/10.1016/j.ajpath.2018.12.009
Deng SP, Chen HP, Zhai Y, Jia LY, Liu JY, Wang M, et al. Molecular cloning, characterization and expression analysis of SPX in spotted scat (Scatophagus argus). Gen Comp Endocrinol. 2018;266:60-66. https://doi.org/10.1016/j.ygcen.2018.04.018
Al-Jubawi MM, Mohammed SB, Al-Abedi RF. The role of asprosin and ceramides in the development of growth hormone deficiency in children. Med J Babylon. 2022;19(4):714-720. https://doi.org/10.4103/MJBL.MJBL_231_22
Corica D, Aversa T, Curro M, Tropeano A, Pepe G, Alibrandi A, Wasniewska M. Asprosin serum levels and glucose homeostasis in children with obesity. Cytokine. 2021;142:155477. https://doi.org/10.1016/j.cyto.2021.155477
Long W, Xie X, Du C, Zhao Y, Zhang C, Zhan D, Luo X. Decreased circulating levels of asprosin in obese children. Horm Res Paediatr. 2019;91(4):271-277. https://doi.org/10.1159/000500523
Behrooz M, Vaghef-Mehrabany E, Ostadrahimi A. Different spexin levels in obese vs normal weight children and its relationship with obesity-related risk factors. Nutr Metab Cardiovasc Dis. 2020;30(4):674-682. https://doi.org/10.1016/j.numecd.2019.11.008
Behrooz M, Vaghef-Mehrabany E, Moludi J, Ostadrahimi A. Are spexin levels associated with metabolic syndrome, dietary intakes and body composition in children? Diabetes Res Clin Pract. 2021;172:108634. https://doi.org/10.1016/j.diabres.2020.108634
Andy T, Wenyuan H, Jim TC, Denise DB. SPX: Its role, regulation, and therapeutic potential in the hypothalamus. Pharmacol Ther. 2022;233:108033. https://doi.org/10.1016/j.pharmthera.2021.108033
Alkubaisi MR, Ali HH, Ali AD, Fakhri J, Rahmah AM. Study of metabolism of bone in Iraqi children with GH deficiency before and after 6 months GH replacement therapy. Syst Rev Pharm. 2020;10:31838-31895. https://doi.org/10.31838/srp.2020.4.95
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2025 Ghufran S. Jawad, Lujain A. Ghannawi, Ahmed L. Hamad, Karam Gharab, Wasnaa H. Abdullah
This work is licensed under a Creative Commons Attribution 4.0 International License.
ISSN: 
